Literature DB >> 29797162

Missed Opportunities for HIV Prevention: Individuals Who HIV Seroconverted Despite Accessing Healthcare.

Francesca Cossarini1, David B Hanna2, Mindy S Ginsberg2, Oni J Blackstock3, Kathryn Anastos3, Uriel R Felsen3.   

Abstract

Individuals with a negative HIV test before a positive one (seroconverters) may represent missed opportunities for prevention. To inform HIV prevention strategies, we aimed to characterize patients who seroconverted despite accessing care. We identified patients at a large, urban healthcare system who seroconverted between 2009 and 2014. Demographics, visits, and HIV-related variables were extracted from the medical records. We performed descriptive statistics, assessed for trends, and tested for associations according to sex. 220 seroconverters were identified: 45% were female, 87% were non-Hispanic Black or Hispanic, and median number of negative tests prior to diagnosis was 2 (IQR 1-3). Overall, 49% reported heterosexual contact as their risk factor and the proportion with heterosexual risk increased over time (24% in 2009 vs. 56% in 2014, p = 0.03). Compared to men, women were older at the time of diagnosis (35 vs. 26 years old, p < 0.01), had more visits between their latest negative and positive HIV test (4 vs. 2, p < 0.01), and were more likely to be diagnosed in the context of screening (64% vs. 56%, p = 0.05). We identified a population that became HIV-infected despite multiple healthcare encounters and undergoing HIV testing multiple times. Patients were mostly heterosexual and almost half were female. To avoid missed opportunities for those already accessing care, HIV prevention efforts should include strategies tailored to individuals with less frequently recognized risk profiles.

Entities:  

Keywords:  Epidemiology; HIV prevention; Missed opportunities; Seroconverters

Mesh:

Year:  2018        PMID: 29797162      PMCID: PMC6204105          DOI: 10.1007/s10461-018-2162-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  21 in total

1.  Compliance with a New York State 2010 HIV Testing Law: Is There Racial/Ethnic Bias in HIV Testing? Experience of Monroe County, New York, 2012.

Authors:  Byron S Kennedy; Anne Kern; John Ricci; Mary Younge; Kathy Carelock; Brenden Bedard; Kim Smith; Roxana Inscho
Journal:  Ethn Dis       Date:  2016-01-21       Impact factor: 1.847

2.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

3.  Investigations of AIDS patients with no previously identified risk factors.

Authors:  K G Castro; A R Lifson; C R White; T J Bush; M E Chamberland; A M Lekatsas; H W Jaffe
Journal:  JAMA       Date:  1988-03-04       Impact factor: 56.272

4.  Predictive Factors for HIV Seroconversion Among Individuals Attending a Specialized Center After an HIV Risk Exposure: A Case-Control Study.

Authors:  Lorna Leal; Berta Torres; Agathe León; Constanza Lucero; Alexy Inciarte; Vicens Diaz-Brito; Elisa de Lazzari; José María Gatell; Felipe García
Journal:  AIDS Res Hum Retroviruses       Date:  2016-08-30       Impact factor: 2.205

5.  Estimated HIV Inter-test Interval Among People at High Risk for HIV Infection in the U.S.

Authors:  Qian An; Ruiguang Song; Teresa J Finlayson; Cyprian Wejnert; Gabriela Paz-Bailey
Journal:  Am J Prev Med       Date:  2017-03-21       Impact factor: 5.043

6.  Characterization of HIV Seroconverters in a TDF/FTC PrEP Study: HPTN 067/ADAPT.

Authors:  Mariya V Sivay; Maoji Li; Estelle Piwowar-Manning; Yinfeng Zhang; Sarah E Hudelson; Mark A Marzinke; Rivet K Amico; Andrew Redd; Craig W Hendrix; Peter L Anderson; Kevin Bokoch; Linda-Gail Bekker; Frits van Griensven; Sharon Mannheimer; James P Hughes; Robert Grant; Susan H Eshleman
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

7.  Correlates of routine HIV testing practices: a survey of New York State primary care physicians, 2011.

Authors:  Mary Zielinski; Shu-Yin J Leung; Tugba Akkaya-Hocagil; Kirsten A Rowe; Christina Ortega-Peluso; Lou C Smith
Journal:  J Acquir Immune Defic Syndr       Date:  2015-01-01       Impact factor: 3.731

8.  Epidemiology of HIV infection in large urban areas in the United States.

Authors:  H Irene Hall; Lorena Espinoza; Nanette Benbow; Yunyin W Hu
Journal:  PLoS One       Date:  2010-09-15       Impact factor: 3.240

9.  HIV Testing Experience Before HIV Diagnosis Among Men Who Have Sex with Men - 21 Jurisdictions, United States, 2007-2013.

Authors:  Laurie Linley; Qian An; Ruiguang Song; Eduardo Valverde; Alexandra M Oster; Xiaona Qian; Angela L Hernandez
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-09-23       Impact factor: 17.586

10.  Factors Associated with Recent HIV Testing among Heterosexuals at High Risk for HIV Infection in New York City.

Authors:  Marya Gwadz; Charles M Cleland; Alexandra Kutnick; Noelle R Leonard; Amanda S Ritchie; Laura Lynch; Angela Banfield; Talaya McCright-Gill; Montserrat Del Olmo; Belkis Martinez
Journal:  Front Public Health       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.